Treating Urogenital Atrophy
Open Access
- 1 September 2005
- journal article
- Published by SAGE Publications in Women's Health
- Vol. 1 (2) , 279-292
Abstract
Urogenital atrophy, although a frequently occurring symptom of aging for all women, is a condition often not thought of as a symptom of distress for older women or a sign of pelvic pathology requiring treatment by clinicians. Rather, many clinicians feel it is an expected consequence of aging, and older women themselves assimilate their lifestyle to the uncomfortable symptoms of dryness, irritation, itching and malodorous discharge. At times, when symptoms become intolerable with coitus, women will abandon sexual intercourse with their partners due to dyspareunia and not seek intervention to reverse the condition owing to embarrassment in raising this sensitive topic. When urogenital atrophy is diagnosed and the patient requests treatment, the gold standard intervention is estrogen, which can either be delivered systemically or vaginally. Since the Women's Health Initiative data, low-dose, vaginally delivered estrogen is recommended.Keywords
This publication has 55 references indexed in Scilit:
- The role of estrogens in female lower urinary tract dysfunctionUrology, 2003
- Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetateFertility and Sterility, 2001
- Urogenital Symptoms and Resulting Discomfort in Non-Institutionalized Dutch Women Aged 50–75 YearsInternational Urogynecology Journal, 2000
- 17β-Estradiol Vaginal Tablet Versus Conjugated Equine Estrogen Vaginal Cream to Relieve Menopausal Atrophic VaginitisMenopause, 2000
- Urogenital Atrophy and Low-Dose Vaginal Estrogen TherapyMenopause, 2000
- Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.Journal of Clinical Oncology, 1997
- Hormones and Sexuality in Postmenopausal Women: A Psychophysiological StudyJournal of Psychosomatic Obstetrics & Gynecology, 1997
- Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal womenMaturitas, 1996
- Comparative study: Replens versus local estrogen in menopausal womenFertility and Sterility, 1994
- Vaginal Atrophy in the Postmenopausal WomanJAMA, 1983